Advisors Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.38M | Sell |
3,085
-185
| -6% | -$142K | 0.04% | 547 |
|
|
2025
Q4 | $2.52M | Sell |
3,270
-156
| -5% | -$106K | 0.04% | 523 |
|
|
2025
Q3 | $1.93M | Sell |
3,426
-1,062
| -24% | -$600K | 0.03% | 610 |
|
|
2025
Q2 | $2.36M | Sell |
4,488
-881
| -16% | -$492K | 0.04% | 530 |
|
|
2025
Q1 | $3.41M | Buy |
5,369
+204
| +4% | +$140K | 0.06% | 413 |
|
|
2024
Q4 | $3.68M | Sell |
5,165
-443
| -8% | -$372K | 0.07% | 382 |
|
|
2024
Q3 | $5.9M | Sell |
5,608
-1,025
| -15% | -$1.14M | 0.11% | 240 |
|
|
2024
Q2 | $6.97M | Sell |
6,633
-984
| -13% | -$954K | 0.14% | 185 |
|
|
2024
Q1 | $7.33M | Sell |
7,617
-757
| -9% | -$720K | 0.14% | 181 |
|
|
2023
Q4 | $7.35M | Sell |
8,374
-1,021
| -11% | -$841K | 0.15% | 163 |
|
|
2023
Q3 | $7.73M | Buy |
9,395
+381
| +4% | +$299K | 0.17% | 137 |
|
|
2023
Q2 | $6.48M | Sell |
9,014
-674
| -7% | -$520K | 0.13% | 174 |
|
|
2023
Q1 | $7.96M | Buy |
9,688
+1,342
| +16% | +$1.01M | 0.16% | 140 |
|
|
2022
Q4 | $6.02M | Buy |
8,346
+458
| +6% | +$338K | 0.12% | 184 |
|
|
2022
Q3 | $5.43M | Sell |
7,888
-144
| -2% | -$90.6K | 0.11% | 199 |
|
|
2022
Q2 | $4.75M | Sell |
8,032
-689
| -8% | -$448K | 0.09% | 249 |
|
|
2022
Q1 | $6.09M | Sell |
8,721
-2,091
| -19% | -$1.32M | 0.09% | 228 |
|
|
2021
Q4 | $6.83M | Sell |
10,812
-2,642
| -20% | -$1.62M | 0.1% | 208 |
|
|
2021
Q3 | $8.14M | Sell |
13,454
-650
| -5% | -$404K | 0.12% | 166 |
|
|
2021
Q2 | $7.88M | Sell |
14,104
-2,889
| -17% | -$1.46M | 0.12% | 169 |
|
|
2021
Q1 | $8.04M | Sell |
16,993
-4,726
| -22% | -$2.3M | 0.13% | 159 |
|
|
2020
Q4 | $10.5M | Sell |
21,719
-537
| -2% | -$290K | 0.17% | 111 |
|
|
2020
Q3 | $12.5M | Sell |
22,256
-1,113
| -5% | -$675K | 0.23% | 79 |
|
|
2020
Q2 | $14.6M | Buy |
23,369
+1,604
| +7% | +$910K | 0.28% | 66 |
|
|
2020
Q1 | $10.6M | Buy |
21,765
+978
| +5% | +$403K | 0.25% | 83 |
|
|
2019
Q4 | $7.8M | Buy |
20,787
+3,297
| +19% | +$1.11M | 0.14% | 171 |
|
|
2019
Q3 | $4.85M | Buy |
17,490
+3,915
| +29% | +$1.16M | 0.09% | 259 |
|
|
2019
Q2 | $4.25M | Buy |
13,575
+3,848
| +40% | +$1.28M | 0.08% | 296 |
|
|
2019
Q1 | $3.99M | Buy |
9,727
+2,478
| +34% | +$1.02M | 0.07% | 320 |
|
|
2018
Q4 | $2.71M | Buy |
7,249
+3,378
| +87% | +$1.24M | 0.05% | 406 |
|
|
2018
Q3 | $1.56M | Sell |
3,871
-1,095
| -22% | -$417K | 0.03% | 687 |
|
|
2018
Q2 | $1.71M | Sell |
4,966
-1,995
| -29% | -$624K | 0.03% | 646 |
|
|
2018
Q1 | $2.23M | Sell |
6,961
-84
| -1% | -$29.2K | 0.04% | 567 |
|
|
2017
Q4 | $2.65M | Buy |
7,045
+198
| +3% | +$80.2K | 0.04% | 531 |
|
|
2017
Q3 | $3.06M | Sell |
6,847
-853
| -11% | -$406K | 0.05% | 477 |
|
|
2017
Q2 | $3.78M | Buy |
7,700
+2,396
| +45% | +$1.05M | 0.06% | 412 |
|
|
2017
Q1 | $2.06M | Sell |
5,304
-1,973
| -27% | -$731K | 0.03% | 620 |
|
|
2016
Q4 | $2.67M | Buy |
7,277
+112
| +2% | +$42.6K | 0.04% | 541 |
|
|
2016
Q3 | $2.88M | Sell |
7,165
-1,735
| -19% | -$696K | 0.05% | 516 |
|
|
2016
Q2 | $3.11M | Sell |
8,900
-492
| -5% | -$189K | 0.05% | 515 |
|
|
2016
Q1 | $3.38M | Sell |
9,392
-4,040
| -30% | -$1.66M | 0.06% | 480 |
|
|
2015
Q4 | $7.29M | Sell |
13,432
-2,013
| -13% | -$1.09M | 0.12% | 252 |
|
|
2015
Q3 | $7.18M | Sell |
15,445
-366
| -2% | -$197K | 0.11% | 260 |
|
|
2015
Q2 | $8.07M | Buy |
15,811
+912
| +6% | +$445K | 0.11% | 251 |
|
|
2015
Q1 | $6.73M | Buy |
14,899
+1,390
| +10% | +$589K | 0.09% | 283 |
|
|
2014
Q4 | $5.54M | Buy |
13,509
+3,062
| +29% | +$1.2M | 0.07% | 324 |
|
|
2014
Q3 | $3.77M | Buy |
10,447
+151
| +1% | +$50.6K | 0.05% | 418 |
|
|
2014
Q2 | $2.91M | Buy |
10,296
+1,153
| +13% | +$342K | 0.04% | 477 |
|
|
2014
Q1 | $2.75M | Buy |
9,143
+758
| +9% | +$234K | 0.04% | 467 |
|
|
2013
Q4 | $2.31M | Buy |
8,385
+215
| +3% | +$61.8K | 0.04% | 472 |
|
|
2013
Q3 | $2.56M | Sell |
8,170
-718
| -8% | -$189K | 0.05% | 440 |
|
|
2013
Q2 | $2M | Buy |
+8,888
| New | +$2.07M | 0.04% | 459 |
|
Other funds holding REGN
VCM
N
Advisors Asset Management's REGN Position: Q1 2026 in Review
Advisors Asset Management reduced its Regeneron Pharmaceuticals (REGN) stake by 5.7% in Q1 2026, selling an estimated $142K and leaving 3,085 shares worth $2.38M. The position accounts for 0.04% of the portfolio, ranked #547.
Advisors Asset Management first reported a position in REGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $14.6M in Q2 2020. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Advisors Asset Management held 3,085 shares of Regeneron Pharmaceuticals worth $2.38M as of Q1 2026.
- Advisors Asset Management sold 185 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $142K.
- Regeneron Pharmaceuticals made up 0.04% of Advisors Asset Management's portfolio in Q1 2026, its #547 holding.
- Advisors Asset Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Advisors Asset Management's Regeneron Pharmaceuticals position peaked at $14.6M in Q2 2020.
- 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Advisors Asset Management's 13F filing for Q1 2026, filed 15 May 2026.